France at odds with European medicines agency over Pill

France insisted Friday on restricting the prescription of newer-generation birth control pills even as Europe's medicines watchdog declared there was no evidence to merit a health warning.

Citing concerns over risks of from the so-called 3rd- and 4th-generation pills, France said it would limit prescriptions of these contraceptives and urged the European Union (EU) to follow suit.

French Marisol Touraine urged the EU to consider a restriction on prescribing the contraceptives and announced a French "directive" to achieve the same.

"We will ask Europe not to suspend but to modify" the prescription guidelines for the pills, said Dominique Maraninchi of the French medicines watchdog, who spoke alongside Touraine at a press conference.

The European Medicines Agency (EMA) earlier said there was no basis for changing guidelines.

"There is currently no new evidence that would suggest any change to the known safety profile of any combined contraceptives marketed today," the agency said in a statement from London.

"Therefore, there is no reason for any woman to stop using her contraception."

add to favorites email to friend print save as pdf

Related Stories

US reviews birth control pill safety over clot risk

May 31, 2011

The US Food and Drug Administration said Tuesday it is reviewing recently published studies which have pointed to an increased blood clot risk associated with a certain type of birth control pill.

Recommended for you

Study recalculates costs of combination vaccines

19 hours ago

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Drug watchdog urges vigilance in cancer drug theft

22 hours ago

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

Pyridoxine-doxylamine drug safety data lacking

Apr 16, 2014

(Medical Xpress)—The most commonly prescribed drug for pregnant women suffering from morning sickness in their first trimester does not prevent birth defects even though drug safety data says it does, according to research ...

User comments